Jeff Reeves

Jeff Reeves

Jeff Reeves is a financial commentator with almost two decades of newsroom and markets experience, including a stint as an editor for the New York Times Co. He has been lead writer and editor for InvestorPlace.com since the beginning of 2010.  

Jeff’s work has appeared in numerous finance publications and broadcast outlets, including The Wall Street Journal network, CNBC, TheStreet.com, Fox Business Channel, USA Today and a host of others.

View some of his TV appearances on YouTube, or check out his writing links below.

Jeff has also penned an eBook, The Frugal Investor’s Guide to Finding Great Stocks: 11 Free Resources to Help Beginners Identify Fantastic Investments.

Write Jeff at editor@investorplace.com, or follow him on Twitter @JeffReevesIP.

Recent Articles

10 Best Cheap Stocks to Buy Now Under $10

If you can handle a little risk, jump into some of the best cheap stocks to buy now before they crash through the ceiling.

Death of Obamacare Means Doom for These Stocks

Healthcare stocks are in turmoil after the election of President Trump, with major insurers rallying while other service stocks are crashing and burning.

3 Best Healthcare Stocks to Buy Now

The best healthcare stocks to buy now include Ventas, Johnson & Johnson and Gilead Sciences -- recession-proof companies with good dividends.

9 Dividend Stocks to Buy Now

If you want stability, these well-priced dividend stocks to buy now will provide a great backbone for your portfolio in 2017.

Buy Twitter Stock Under $16, Sell Over $19, Then Repeat

Buy Twitter stock on a dip after negative news like earnings, sell on a pop after buyout rumors for a 20% gain. Then repeat until rich!

9 Best Stocks to Buy Amid Market Turmoil

The best stocks to buy in tough times are stable dividend-payers like these nine market-beating picks.

Barracuda Networks Inc. (NYSE:CUDA) a Big Buy after Earnings

Barracuda Networks Inc. (NYSE:CUDA) just posted strong earnings, and CUDA stock is a great buy amid a focus on cybersecurity.

Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!

Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report.

7 Stock Charts to Watch in October

These seven stock charts tell a few stories, including a few unknown companies that could break higher and a few big-name stocks that could fall apart.

The 10 Best S&P 500 Stocks of Q3 2016

The best S&P 500 stocks of 2016 are mostly being driven by just two trends. Here's a look at the year's best stocks, and why they're soaring.